Publication:
Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy

Thumbnail Image

relationships.isOrgUnitOf

Program

relationships.isAuthorOf

Author

Bozbay, Mehmet

Uyarel, Huseyin

Avsar, Sahin

Oz, Ahmet

Keskin, Muhammed

Tanik, Veysel Ozan

Bakhshaliyev, NIJAD


Pehlivanoglu, Seckin

Eren, Mehmet

Advisor

Date

2015-12-01T00:00:00Z

Language

Type

Article

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.

Description

Source

Keywords

Keywords

Citation

Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O. , Bakhshaliyev N., Ugur M., Pehlivanoglu S., Eren M., -Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy-, JOURNAL OF CRITICAL CARE, cilt.30, ss.1179-1183, 2015

URI

http://hdl.handle.net/20.500.12645/27924

Collections

Yayınlar - Eserler

Endorsement

Review

Supplemented By

Referenced By

3

Views

0

Downloads

View PlumX Details


Sustainable Development Goals